Gabapentin Titration Schedule
When increasing gabapentin from 100 mg, titrate by adding 100-300 mg every 1-7 days as tolerated, targeting an effective dose of 1800-3600 mg/day divided three times daily. 12
Starting from 100 mg: Recommended Titration Approach
The FDA-approved titration schedule provides the clearest guidance 2:
- Day 1: 300 mg once daily (or at bedtime)
- Day 2: 600 mg/day (300 mg twice daily)
- Day 3: 900 mg/day (300 mg three times daily)
- Subsequent increases: Add 100-300 mg increments every 1-7 days based on tolerability
Since you're starting at 100 mg, you can either:
- Jump directly to the standard 300 mg TID schedule if tolerated
- Increase more gradually by 100-200 mg every few days if concerned about side effects
Target Dosing
For neuropathic pain: The minimum effective dose is typically 1800 mg/day (600 mg three times daily), though doses up to 3600 mg/day may be needed 12. Clinical studies show efficacy across the 1800-3600 mg/day range, with comparable effects, though additional benefit above 1800 mg/day was not consistently demonstrated 1.
For epilepsy: Maintenance doses range from 900-2400 mg/day in adults, with some patients requiring up to 3600 mg/day 2.
Key Titration Principles
Gabapentin has nonlinear pharmacokinetics due to saturable absorption, which is why careful, gradual titration is essential 11. This distinguishes it from pregabalin, which has linear kinetics and more straightforward dosing.
Timing considerations:
- Maximum interval between doses should not exceed 12 hours 2
- Always divide total daily dose into three administrations
- An adequate therapeutic trial requires 3-8 weeks for titration plus 2 weeks at maximum tolerated dose 11
Managing Side Effects During Titration
The most common dose-dependent adverse effects are dizziness and sedation 11. These can be minimized by:
- Starting with lower doses (100-300 mg at bedtime initially)
- Titrating slowly over 1-7 days between increases
- Taking the largest dose at bedtime if sedation is problematic
Research shows that even rapid initiation at 900 mg/day is well-tolerated except for higher rates of dizziness 3, but starting lower from 100 mg allows better tolerance assessment.
Special Populations
Renal impairment: Reduce doses proportionally based on creatinine clearance. For CrCl 30-59 mL/min, maximum is 1400 mg/day; for CrCl 15-29 mL/min, maximum is 700 mg/day 2.
Elderly patients: Use lower starting doses and slower titration due to higher likelihood of decreased renal function 12.
Common Pitfalls to Avoid
- Don't stop at subtherapeutic doses: Many patients receive inadequate doses below 1800 mg/day 4. If pain persists at lower doses, continue titrating upward.
- Don't rush the trial period: Full assessment requires 2+ months, as efficacy may take weeks to manifest 11.
- Don't abruptly discontinue: Taper gradually over minimum 1 week when stopping 2.
- Don't exceed 12-hour dosing intervals: This compromises steady-state levels and efficacy 2.